Combination therapy for the treatment of pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Combination therapy for the treatment of pulmonary arterial hypertension.

Combination therapy for the treatment of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37919235

about

Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats.Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form.Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.

P2860

Q33805945-0B9A96A6-46BD-48B7-B56C-AE4F47D5029E Q36239561-D0A67E3D-ED7A-40A3-9AC5-BA317D0AFCE6 Q36539532-A8388228-49A4-4D8B-970D-672420B94844 Q36753853-C695CECB-5441-40B4-90C4-686D136067A3 Q41410888-2342C66B-742C-4403-8D24-585573C76C5D Q41625552-2EA68788-FC92-484B-B7D3-C4354E3B1A73 Q43947280-594763F4-85B4-4090-A959-AA5DAE99F478

P2860

Combination therapy for the treatment of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37919235

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Combination therapy for the treatment of pulmonary arterial hypertension.

@en

Combination therapy for the treatment of pulmonary arterial hypertension.

@nl

type

label

Combination therapy for the treatment of pulmonary arterial hypertension.

@en

Combination therapy for the treatment of pulmonary arterial hypertension.

@nl

prefLabel

Combination therapy for the treatment of pulmonary arterial hypertension.

@en

Combination therapy for the treatment of pulmonary arterial hypertension.

@nl

P1433

Q37919235-A635655A-3FC2-42D2-8775-8285DC276651

P1476

Q37919235-1BC5B69B-A544-415D-BACE-3E415D14649A

P2093

Q37919235-1BA551EC-E2D7-4E3C-B237-B410CDEA7357

Q37919235-8FA7D29E-8254-4974-82C3-569DA0F87475

P2860

Q37919235-196BFFE3-864C-4702-B716-F6E0E2CA042B

Q37919235-1C566E56-D214-408A-999A-683B460AF3EA

Q37919235-301BF18F-B965-4788-9302-410511F65D39

Q37919235-30621684-7D4C-4712-BA2A-C51C277D662C

Q37919235-32F8EDEE-F6BF-413B-8684-CFB68E3036A2

Q37919235-36D97EBA-7C42-4016-B7D2-6BCD046D11A4

Q37919235-446C95AC-D212-4F44-ABEE-75CF26812869

Q37919235-53FB0EA6-F05F-4EA3-986A-EAB6907B84A1

Q37919235-555B1F8F-8B23-485C-BF4A-44258EDDA70B

Q37919235-5D27D784-858B-47C9-9B2D-B0CC3ED0C62B

P304

Q37919235-AF5C0E29-A505-4C84-8B90-62EF49843D6B

P31

Q37919235-F43F2E5D-2684-4D6F-9F84-E183D02F6303

P356

Q37919235-C8C0A691-5AD3-4686-B6C7-85F5F67BAEB8

P433

Q37919235-91440CF7-5C3A-490D-9C90-1CF849643DA2

P478

Q37919235-BE2557F5-4D72-4F2B-8E30-4D18A3376344

P577

Q37919235-0729FCF2-372C-4C16-B8CD-2C7131B95566

P698

Q37919235-47869F6B-7216-4E04-940E-044F0703A6DF

P921

Q37919235-CE85A7B8-60B5-4831-A327-E4647C25D418

P356

1753465811411602

P1433

Therapeutic advances in respiratory disease

P1476

Combination therapy for the treatment of pulmonary arterial hypertension.

@en

P2093

Andrew T Levinson

http://www.w3.org/2001/XMLSchema#string

James R Klinger

http://www.w3.org/2001/XMLSchema#string

P2860

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Updated clinical classification of pulmonary hypertension.

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Diagnosis and assessment of pulmonary arterial hypertension.

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

P304

419-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753465811411602

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21849335

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension